Literature DB >> 9346944

Phage display selection on whole cells yields a peptide specific for melanocortin receptor 1.

M Szardenings1, S Törnroth, F Mutulis, R Muceniece, K Keinänen, A Kuusinen, J E Wikberg.   

Abstract

A phage display system for the selection of peptides binding to heterologously expressed human melanocortin receptor 1 on the surface of insect cells has been established. It could be shown that phage particles displaying the natural ligand alpha-melanocyte-stimulating hormone bind selectively to cells expressing this receptor and that these phages exhibit biological activity on mouse B16F1 melanoma cells. Insect cells were superior to other cell lines tested and have been used to select binders from a small library, in which critical determinants (Phe7-Arg8-Trp9) were kept, whereas the flanking regions where allowed to variate freely. One peptide displaying little similarity with native hormone was found that binds to the receptor also in its free form with an affinity of 7 nM. It showed a remarkable selectivity for this receptor, because it binds to the other melanocortin receptor subtypes with a maximum affinity of 21 microM. This is the first time phage display has been used successfully with G-protein-coupled receptors lacking an extracellular binding domain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346944     DOI: 10.1074/jbc.272.44.27943

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Peptide antagonists of the plasmodesmal macromolecular trafficking pathway.

Authors:  F Kragler; J Monzer; B Xoconostle-Cázares; W J Lucas
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Heteroduplex mobility assay (HMA) pre-screening: an improved strategy for the rapid identification of inserts selected from phage-displayed peptide libraries.

Authors:  F Fack; S Deroo; S Kreis; C P Muller
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

Review 3.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

4.  Novel beta-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy.

Authors:  Girja S Shukla; David N Krag
Journal:  J Drug Target       Date:  2010-02       Impact factor: 5.121

Review 5.  Phage-displayed peptide libraries.

Authors:  M B Zwick; J Shen; J K Scott
Journal:  Curr Opin Biotechnol       Date:  1998-08       Impact factor: 9.740

6.  Cancer cell-specific internalizing ligands from phage displayed beta-lactamase-peptide fusion libraries.

Authors:  Girja S Shukla; David N Krag
Journal:  Protein Eng Des Sel       Date:  2010-03-10       Impact factor: 1.650

7.  Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A.

Authors:  H C Wu; C T Yeh; Y L Huang; L J Tarn; C C Lung
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

Review 8.  Malignant melanoma and melanocortin 1 receptor.

Authors:  A A Rosenkranz; T A Slastnikova; M O Durymanov; A S Sobolev
Journal:  Biochemistry (Mosc)       Date:  2013-11       Impact factor: 2.487

9.  DNA display selection of peptide ligands for a full-length human G protein-coupled receptor on CHO-K1 cells.

Authors:  Nobuhide Doi; Natsuko Yamakawa; Hideaki Matsumoto; Yasutsugu Yamamoto; Tetsuya Nagano; Nobutaka Matsumura; Kenichi Horisawa; Hiroshi Yanagawa
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

10.  Phage displayed short peptides against cells of Candida albicans demonstrate presence of species, morphology and region specific carbohydrate epitopes.

Authors:  Soshee Anandakumar; Kannan Narayanarao Boosi; Harigopalarao Bugatha; Bhavna Padmanabhan; Parag P Sadhale
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.